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ABSTRACT 
Background 
With the continuing development of nanomaterials, the assessment of their potential impact 
on human health, and especially human reproductive toxicity, is a major issue. The testicular 
biodistribution of nanoparticles remains poorly studied. This study investigated whether gold-
silica nanoparticles could be detected in mouse testes after intramuscular injection, with a 
particular focus on their ability to cross the blood–testis barrier. To that purpose, well-
characterized 70-nm gold core–silica shell nanoparticles were used to ensure sensitive 
detection using high-resolution techniques. 
Results 
Testes were collected at different time points corresponding to spermatogenesis stages in 
mice. Transmission electron microscopy and confocal microscopy were used for nanoparticle 
detection, and nanoparticle quantification was performed by atomic emission spectroscopy. 
All these techniques showed that no particles were able to reach the testes. Results accorded 
with the normal histological appearance of testes even at 45 days post sacrifice. 
Conclusion 
High-resolution techniques did not detect 70-nm silica-gold nanoparticles in mouse testes 
after intramuscular injection. These results are reassuring about the safety of nanoparticles 
with regard to male human reproduction, especially in the context of nanomedicine. 
KEY WORDS 
Nanoparticles, mice, testes, intramuscular injection, reproductive toxicity. 
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INTRODUCTION 
During the last 20 years, nanotechnology has drastically evolved, leading to increasing 
population-level exposure to engineered nanoparticles and nanomaterials. A wide variety of 
fields, such as the textile industry, computer sciences, cosmetics, and medicine, have taken 
advantage of nanostructured compounds. Their intrinsic small size and high surface reactivity 
(Oberdörster et al. 1994), which could allow specific interactions with biological structures, 
raise concerns in the scientific community about potential environmental or human health 
toxicity (Peralta-Videa et al. 2011). Concomitantly, declining sperm counts have been 
documented in most Western countries (Lackner et al. 2005; Rolland et al. 2013). Thus, 
concerns have been raised about the ability of nanoparticles to impair human reproduction, 
especially male fertility (Ema et al. 2010; Lan and Yang 2012). Two types of studies have 
focused on this topic: (1) testicular biodistribution and biopersistence studies and (2) testicular 
biotoxicity studies. 
With regard to biodistribution, all studies performed in mice or rats have concluded that very 
limited amounts of nanoparticles can reach the testes regardless of the exposure routes 
(inhalation, intravenous, oral) and the physico-chemical properties of nanoparticles, including 
carbon nanotubes and gold, cerium oxide, silica and silver nanoparticles measuring between 
10 and 5000 nm (Bai et al. 2010; Balasubramanian et al. 2010; Geraets et al. 2012; De Jong et 
al. 2008; Lankveld et al. 2010; Lan and Yang 2012; Morishita et al. 2012; Park et al. 2010; 
van der Zande et al. 2012). Most studies agree that the testes is a minor target for distribution 
of nanoparticles compared with other organs (Geraets et al. 2012; De Jong et al. 2008; 
Lankveld et al. 2010). However, the studies are not entirely consistent. Nanoparticle size 
variation may explain some of these discrepancies (De Jong et al. 2008; Morishita et al. 2012; 
Park et al. 2010), and exposure route and particles agglomeration may also contribute to the 
differences. Testicular biopersistence of nanoparticles seems to depend on exposure route; for 
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instance, biopersistence of silver nanoparticles was less than 2 weeks following intravenous 
exposure (Lankveld et al. 2010), but more than 4 months after oral exposure (Lee et al. 2013; 
van der Zande et al. 2012). Furthermore, some authors have suggested that nanoparticles 
could cross the blood–testis barrier, but only Moroshita et al. (2012) have provided evidence. 
Their study in mice demonstrated the presence of nanoparticles in spermatocytes after an 
intravenous injection of 70-nm silica nanoparticles. 
Regarding testicular biotoxicity, three concerns have been raised: reduction in daily sperm 
production (Gromadzka-Ostrowska et al. 2012; Xu et al. 2014; Yoshida et al. 2009), although 
this outcome is not reported by all authors (Bai et al. 2010); increase in testosterone synthesis 
(Li et al. 2009; Ramdhan et al. 2009; Tassinari et al. 2014; Yoshida et al. 2009); and the 
appearance of histological abnormalities. Histological analysis of mice testes after multiple 
intravenous injections of carbon nanotubes showed damage to seminiferous tubules, 
particularly reductions in the thickness of the germinative layer and the number of germ stem 
cells; however, the abnormalities resolved after 60 days (Bai et al. 2010). Gromadzka-
Ostrowska et al. (2012) showed that intravenous injection of 200-nm silver nanoparticles in 
rats induced enlargement of intercellular spaces and vacuolization of the germinal epithelium, 
while 20-nm silver nanoparticles did not have the same effects. In another study, inhalation of 
carbon black nanoparticles of 14–95 nm in mice led to the degeneration of some seminiferous 
tubules compared to the control group (Yoshida et al. 2009).  
In contrast, Morishita et al. (2012) revealed that although intravenously injected 70 nm silica 
particles reached the testes, they did not trigger any histological abnormalities in mice. 
Similarly, Chen et al. (2013) found no testicular histological abnormalities after 
intraperitoneal injection of pegylated gold nanoparticles in mice, (Chen et al. 2013) and Xu et 
al. (2014) did not find any histological changes in mice testes after 13 days of intravenous 
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exposure to silica nanoparticles, apart from reversible ultrastructural changes in mitochondria. 
Finally, no study has found any impact of nanoparticles on testis weight. 
In a previous study, we demonstrated the presence of individual 450-nm fluorescent particles 
in the testes after intramuscular injection in mice (Klein et al. 2013). The intramuscular route 
was specifically chosen because it is normally used for vaccine delivery, and nanoparticles are 
increasingly being used and explored as vaccine adjuvants (Gregory et al. 2013; Oyewumi et 
al. 2010; Peek et al. 2008). However, to our knowledge, no other reports have been published 
about testicular biodistribution or biotoxicity of nanoparticles used as vaccine adjuvants. 
Given that some works have shown that smaller nanoparticles induce better immunogenicity 
(Fifis et al. 2004) and trigger better cellular immune responses (Oyewumi et al. 2010), we 
studied the testicular biodistribution of smaller particles (70-nm gold core–silica shell 
nanoparticles) after intramuscular injection in mice. The hybrid nature of these particles 
allowed (i) an easy detection by high-resolution transmission electron microscopy (TEM) and 
inductively coupled plasma–atomic emission spectroscopy (ICP-AES) due to the gold core, 
and (ii) fluorescence detection due to the FITC dyes encased within the silica shell. The 
histological morphology of testes was also examined to identify any possible morphological 
alterations in the blood–testis barrier by the presence of particles; the cellular integrity of the 
seminiferous epithelium was also verified. 
  
6 
 
METHOD 
Nanoparticles synthesis and characterization 
All colloidal solutions used for biodistribution assays were provided by the ILM laboratory 
and consisted of 5-nm gold cores coated with a 65-nm polysiloxane shell (SiOx) doped with 
fluorescein molecules. The particle surface was functionalized by the addition of -COOH 
groups to ensure long-term stability for biological assays. Fluorescein dyes covalently 
entrapped within a silica matrix were chosen for their strong emission luminescence at 518 
nm as tracers for epifluorescence microscopy detection (Olympus). Briefly, the colloidal 
solution was prepared according to a previous method (Martini et al. 2009) based on sol-gel 
synthesis in a water/oil microemulsion to control the size, dye amount, and homogeneity of 
the particle population. Thereafter, particles were purified by ultrafiltration using 300 kDa 
PES membranes (with a purification rate higher than 108) and then dispersed in aqueous 
solution (20 g.L-1) for further dilutions. 
The detailed structural and morphological examination of samples was carried out by 
transmission electron microscopy (TEM) using a HITACHI H-800 microscope. The samples 
were prepared by depositing a drop of diluted colloidal solution onto a carbon grid (200 mesh) 
and allowing the solvent to evaporate at room temperature. Measurements of the 
hydrodynamic size and the Zeta-potential were performed on a Dynamic Light Scattering 
apparatus (Zetasizer NanoZS, Malvern).  
 
Animals 
Eighteen male C57BL6 mice (Centre d’Elevage René Janvier, France) were housed at the 
animal experimental platform of the Jean Monnet University (PLEXAN – Plateforme 
d’EXpérimentation et ANalyses, Agreement number 42-18-0801) and all experiments were 
performed in compliance with the French laws and institutional guidelines. An authorization 
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approving the experiments was obtained from the French Ministère de l’Enseignement 
Supérieur et de la Recherche (MESR, field number 00462.02). Experiments were started 
when the mice were between 6 and 8 weeks of age. 
 
Intramuscular injection of nanoparticles 
Particles were diluted in physiological water and a volume of 50 µL was injected in each 
tibialis anterior muscle of 15 mice, for a total amount of 1.6 × 1013 particles per mouse. Three 
mice received an injection containing only physiological water and constituted the negative 
control group. 
 
Biological samples 
The 15 injected mice were divided into five groups and sacrificed by cervical dislocation after 
1 h (H1), 4 days (D4), 21 days (D21), 36 days (D36), or 45 days (D45) post injection. These 
time points coincide with the duration of spermatogenesis in mice. For each series, testes were 
excised and prepared for characterization (ICP-AES, histological analysis, TEM, and confocal 
microscopy); mice from the control group were sacrificed after 45 days. To that purpose testes 
were obtained and then subdivided in several pieces for the various investigations. 
Mice were immobilized and their urine was collected in a tube; blood was collected by retro-
orbital puncture just before sacrifice. The silica-gold nanoparticles’ structural stability as well 
as their capacity to translocate from the site of injection were assessed by TEM in whole 
blood and by ICP-AES in urine samples, respectively.  
 
Induced Coupled Plasma–Atomic Emission Spectroscopy 
At each time point, testes were excised, weighted, mechanically dilacerated, and incubated 
overnight in a bath of 6 M HCl under agitation. Samples were then dried at 90°C and diluted 
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in 2 M HCl before ICP analyses of the amount of gold using adequate controls (ICP-AES, 
Horiba Jobin Yvon Activa-S coupled with Jobin Yvon AS 421 autosampler). 
The same protocol was used to evaluate the levels of gold in urine samples. 
 
 
Histological analysis 
Freshly excised testes were cut and fixed in Japanese fixator (3% paraformaldehyde, 2% 
sodium cacodylate, and 0.2% picric acid), then rinsed three times (5 min per wash) in sodium 
cacodylate, and finally dehydrated in two acetone baths (30 min each). Samples were 
impregnated overnight at 4°C in glycolmethacrylate (GMA) and then embedded in resin 
(GMA and aniline/propanol solution) at 4°C until complete polymerization. 
Nonadjacent 3-µm-thick sections of resin-fixed testes were prepared using a microtome 
(Leica RM 2065). The sections were placed on slides (Superfrost Plus, Thermo Scientific), 
stained with Masson Trichrome stain, dried, and mounted with an appropriate mounting 
medium (Eukitt®: Sigma, France). Since the mouse testis is a homogenous organ, we 
considered each section as representative of the whole testis. Observations were performed 
with an optical microscope (Nikon Eclipse 80i) coupled with a digital-sight Nikon camera and 
a series of microscope objectives (×10, ×40, ×60). The samples were randomly and blindly 
observed. 
 
Transmission Electron Microscopy 
Freshly excised testes were fixed with a solution of 2% paraformaldehyde, 4% 
glutaraldehyde, 0.2 M monosodium dipotassium buffer at pH 7.4. Testes samples of about 1 
mm
3
 were then cut and washed five times in 0.175 M monosodium dipotassium buffer and 
postfixed in 2% osmium tetroxide. After washing, samples were dehydrated by graded series 
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of ethanol baths (30%, 50%, 70%, 90%, 100%) with a last bath in a transition solvent 
(propylene oxide) before embedding in EPON 812 resin. Samples were then sliced using an 
ultramicrotome (Leica, MTXL). 
For conventional TEM studies, 65-nm-thick slices were deposited on Formvar MESH Grid 
and contrasted by means of uranyl acetate and lead citrate. TEM observations, up to 
magnification ×150,000, were carried out on the samples using a H-800 electron microscope 
(Hitachi) at 75 kV. Once filtrated and deposited on copper grids, whole blood samples were 
also analyzed by TEM without the use of contrasting agents. 
For elemental gold analysis, slices were deposited onto TEM copper grids covered with 
carbon film and contrasted only by means of uranyl acetate. High-resolution (HR) TEM 
studies with electron dispersive X-ray (EDX) analyses were performed using a TOPCON 
electron microscope capable of a 0.18-nm point to point resolution (EM-002B Ultra High 
Resolution Analytical Electron Microscope) operated at 120 kV equipped with EDX detector 
(Thermo Electron Corporation Noran SI X system). For first step HR imaging some slices 
were deposited onto TEM copper grids covered with carbon film and contrasted only by 
means of uranyl acetate. For elemental Au analysis, slices deposited on carbon film grids 
were prepared without coloration: no uranyl acetate nor lead citrate. 
 
 
Confocal microscopy 
A portion of the samples was placed in a cryopreservative solution (Tissue-Tech®: Sakura, 
Netherlands) and cryoconserved in liquid nitrogen. For confocal analyses, 10-µm slides were 
cut with a cryostat at −20°C (Leica CM-3000). Sections were then dried, mounted with an 
appropriate mounting medium (Fluokeep®: Argene, France), and stored at 4°C in the dark. 
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Analyses were performed using a confocal microscope TCS-SP2 (Leica® Microsystems, 
Heidelberg, Germany) coupled to an inverted microscope with oil immersion objective (HCX 
APO L U-V-I 63 9 1.2 NA), and fitted with acousto-optical beam splitter covering a 350–850 
nm wavelength range. 
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RESULTS 
Nanoparticles characterization 
Physico-chemical features of the nanoparticles are reported in Figure 1. The monoexponential 
correlation function obtained allows us to determine the Z-average, polydispersity index, and 
zeta potential values before the application. The size distribution of nanoparticles (Fig. 1A) 
assessed by dynamic light scattering showed an average diameter of 70 nm with negligible 
variation. The good homogeneity of the particle size as well as the absence of particle 
agglomeration allowed the use of colloidal solutions for biodistribution assays. As expected, 
the zeta potential at physiological pH (Fig. 1B) was negative and equal to −13 mV, due to the 
covalently grafted carboxylate surface groups. On TEM images (Fig. 1C) the gold core was 
highlighted by dark-contrast spot at the center of the particle, this picture also illustrates the 
good reproducibility of the nanoparticle synthesis. The fluorescent signal of the particles was 
validated using epi-fluorescent microscopy (Fig. 1D). 
The presence of silica-gold nanoparticles in whole blood samples was assessed by TEM and 
in urine samples by ICP-AES, as shown in Figure 2. A significant amount of gold was 
detected in urine at H1 and D4 (Fig. 2A) and nanoparticles were observed in blood samples at 
D4 and D21 (Fig. 2B), indicating that nanoparticles were able to leave the site of injection and 
maintain their integrity over time in biological media. 
 
ICP quantification 
The presence of gold was quantified in the testes using the ICP-AES technique. A dilution 
series of nanoparticles was performed to assess the detection limit of the technique (1/10, 
1/100, 1/500, 1/1000, 1/10,000, 1/100,000). These preliminary data showed that under a 
1/100,000 dilution the ICP technique was not able to detect gold in the samples, defining a 
threshold of 1.6 × 108 nanoparticles (data not shown). 
12 
 
Figure 3 summarizes the estimated amount of gold in the testes (expressed in ppm) 
normalized by the organ weight. A positive control corresponding to the same amount of 
nanoparticles injected directly into a freshly excised testis was used. Regardless of the time of 
analysis after exposure, gold amounts were very weak, indicating a negligible testicular 
presence of the nanoparticles after intramuscular injection. A calibration curve revealed that 
less than 1 out of 105 nanoparticles reached the testis. 
 
Histological observations 
After Masson Trichrome staining, tissue sections from control mice and mice injected with 
the nanoparticles were compared to investigate potential histological alterations (Fig 4). 
Regardless of the time of analysis, the testis generally appeared well preserved, without 
morphological alterations. Even after 45 days of exposure, no tubule necrosis or histological 
disorganization at the level of germinal cells and spermatozoids were observed, either in the 
intertubular spaces with blood vessels or in the Leydig cells. Moreover, the Sertoli cells, 
which form the blood–testis barrier that might be able to internalize nanoparticles, appeared 
morphologically normal and abundant. The proportion of each cell type seemed normal at 
each time of exposure (Fig 4 A and B). 
Only small alterations of tubules were occasionally observed on the slides, irrespective of the 
time of analysis. Similar alterations were also seen on the control slides, indicating no 
correlation with the nanoparticle exposure (Fig 4 C, D, E). Some giant germinal cells with 
large vacuolized cytoplasm as well as desquamation of the germinal cells in the lumen of 
tubules were observed. 
A particular alteration was noticed on one mouse at D4, with empty tubules showing only 
Sertoli cells without germinal cells (Fig 4F). Although this type of alteration is compatible 
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with a toxic event, in this case it was considered to be an artifact because it was observed very 
soon after exposure and was observed only for a single mouse. 
 
TEM studies 
TEM observations can give information about the inner morphology of testes as well as the 
spatial distribution of nanoparticles present in the tissues. Analyses were performed on the 
testes with a multiscale approach to detect whether nanoparticles were present. The mouse 
testis is a homogenous organ, with repetitions of the morpho-functional unit corresponding to 
the seminiferous tubule surrounded by the intertubular spaces, which contain the Leydig cells. 
Thus, it was assumed that each sliced section was representative of the whole testis. To 
visualize all the structures at each time point, 40 slices per sample were observed. This 
reduced any systematic error due to the specific choice of a few slices. 
First, conventional (Hitachi microscope) TEM observations (Fig. 5) were performed for the 
detection of nanoparticles in the samples. All slices were carefully imaged and entirely 
inspected. Cellular structures such as cytoplasmic vacuoles in Sertoli and germinal cells and 
the intertubular spaces containing the Leydig cells were studied to find nanoparticles. 
Particular care was taken in examining the seminiferous tubules (two to three tubules sections 
contained in each slice) to determine if nanoparticles can cross the blood–testis barrier. For 
each time point of the spermatogenesis process, no nanoparticles were identified in any of the 
regions of interest. One fourth of the sections were selected for HR imaging coupled with 
EDX analysis using the TOPCON microscope (Fig 6). No contrast metallization of the slices 
was performed to suppress the background noise from lead and uranyl compounds, and 
consequently the signal of the copper grid was detected on the spectra. Reference data were 
recorded from a control sample (Fig 6A) obtained from a section slice covered by a drop of 
the silica-gold nanoparticle suspension. An area imaged in Fig. 6A displays the characteristic 
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features of the silica-gold nanoparticles, and the EDX spectrum recorded on the 
corresponding slice region exhibits a well-marked peak resulting from the contributions of the 
silicon and gold elements in addition to the peaks from copper and osmium. The results from 
the D45 samples reproduced in Figure 6B are representative of those for all other time points. 
Again the slices were carefully inspected by high resolution/high magnification imaging (Fig. 
6B) and no indication of the nanoparticles (morphology, size, contrast) could be identified on 
the images. The corresponding EDX spectra showed only a weak peak, corresponding to the 
osmium post-fixing agent included in the samples during the preparation, but no silicon-gold 
peak. Similar spectra were observed for series of samples, revealing the absence of the 
silicon-gold signal. The problem of the Minimum Detectable Mass (MDM) of a given 
element in a given matrix has been investigated both theoretically and experimentally (Reimer 
1989; Williams 1984). For the TEM / EDX system used here and operated in the conditions of 
the present studies the MDM of a heavy element like Au in a biological thin foil (light 
elements with a very small concentration of osmium) should be a few 10-19 g, whereas the 
mass of one 5 nm gold core is more than 10-18 g. Thus the cross correlation of HR imaging 
inspection with corresponding EDX analysis supports the conclusion that there is no gold core 
nanoparticle in the observed sections.  
 
Confocal observations 
To optimize fluorescein emission detection, reflection imaging was used to visualize testes, 
avoiding tissue autofluorescence as demonstrated in our previous study (Klein et al. 2013). 
For all samples, five slices were screened for each time point without being able to distinguish 
any fluorescent nanoparticles (Fig 7A–7F). Cellular structures appeared fluorescent on the 
samples, even on the negative control within the intertubular spaces. These areas 
corresponded to red blood cells, which are known to be autofluorescent. 
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DISCUSSION 
The aim of this study was to assess the testicular biodistribution of 70-nm gold-silica 
nanoparticles after intramuscular injection in mice and to define their histological 
reproductive toxicity. As previously mentioned, the use of nanoparticles as a vaccine adjuvant 
is promising due to their ability to enhance immune response. However, safety has been 
poorly documented, especially considering the intramuscular exposure route. This study was 
intended to address this issue. The nanoparticles were designed to be detectable by several 
complementary methodologies (epi-fluorescence and confocal microscopy, ICP-AES, 
electron microscopy). All of the physico-chemical properties as well as the morphology and 
stability of tracers were validated before the nanoparticles were injected into mice. The ability 
of nanoparticles to enter the circulatory system and their stability in the blood were assessed 
by observing them in blood samples at D4 and D21 using TEM. It was also shown that 
significant amounts of particles were excreted through urine at H1 and D4. 
Here an original multiscale approach using high-resolution methodologies (confocal 
microscopy, ICP-AES, TEM, and EDX) was achieved. Regarding qualitative techniques, 
especially confocal microscopy, though testicular autofluorescence remained a problem 
despite the use of reflection imaging, the present image features do not seem indicative of the 
presence of nanoparticles. Testicular autofluorescence is mainly in the visible spectrum, so we 
are currently developing Cyanine 5.5–doped nanoparticles of the same size (70 nm): their 
emission is centered in the near infrared region, which will help us to reduce background 
noise and obtain more reliable results using confocal microscopy. ICP-AES detection 
threshold for the nanoparticles used in this study was estimated to be 1.6 × 108 nanoparticles, 
which corresponded to 1/100,000 of the injected dose. The use of other measurement 
techniques such as ICP-MS could improve the sensitivity of nanoparticles detection by 
reducing this threshold. Despite the limitations of confocal microscopy and ICP-AES 
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techniques their correlation with the conclusive results of present imaging and analysis TEM 
studies supported the conclusion that nanoparticles were absent in the testes. 
Previous biodistribution studies showed that small amounts of sub-micrometric particles 
reached the testes, depending on experimental conditions. For example, after a single 
intravenous injection of 5 mg/kg of carbon nanotubes in mice, 151 ng of particles were found 
in testes 24 h later, corresponding to about 0.1% of the injected particles (Bai et al. 2010). 
Lankveld et al. (2010) found comparable results after intravenous injection of 20-nm silver 
nanoparticles for 5 days. Testicular distribution of 80-nm and 110-nm particles was also 
observed in very low amounts. De Jong et al. (2008) reported that after intravenous injection 
of 80 µg of 10-nm gold nanoparticles in rats, 55 ng/g was found in the testes, which means 1 
out of 100,000 particles. Balasubramanian et al. (2010) observed similar results with a small 
amount of 20-nm gold nanoparticles (3 µg per rats) injected intravenously. Lee et al. (2013) 
also showed that about one 10- or 25-nm silver nanoparticle out of 106 was able to reach the 
rat testis after 4 weeks of oral exposure. Our previous results showed that 1 out of 107 450-nm 
particles injected by the intramuscular route was found in the testes (Klein et al. 2013). In the 
present study, using smaller particles (70 nm), it was observed that less than 1 out of 105 
nanoparticles was able to reach the testes after intramuscular injection. This result seems in 
agreement with other quantitative studies about particles larger than 50 nm injected by 
intravenous route, which tend to be either not distributed in testes or distributed in very small 
amounts (Morishita et al. 2012). Similarly, De Jong et al. (2008) also demonstrated that 50-, 
100-, and 250-nm particles were unable to reach testes(De Jong et al. 2008). Therefore, 
despite different exposure routes, the results tend to support the same conclusion, suggesting 
that nanoparticle size could be a key point for differences in testicular biodistribution. 
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In this study, we also confirmed that no morphological alterations of the testes were apparent 
as a result of exposure to nanoparticles. This result is in accordance with Morishita et al. 
(2012) and Chen et al. (2013).  
To put the low testicular distribution of nanoparticles observed in this study into perspective 
with the risk of reproductive toxicity of nanoparticles in real-life situations, in vitro studies are 
useful. Indeed, these investigations are complementary to in vivo models and provide 
additional information. The use of cell lines is particularly appropriate for the investigation of 
the mechanisms or thresholds of toxicity. Asare et al. (2012) showed that after murine 
testicular cells underwent a 48-h exposure to 10 µg/ml of silver nanoparticles, the metabolic 
activity measured by MTT assay was reduced and the number of necrotic cells was slightly 
increased; however, other toxic effects, such as apoptosis and DNA damage, were only 
observed for higher concentrations (Asare et al. 2012). It was also shown that carbon black 
nanoparticles at a concentration of 10 µg/ml were able to increased StAR expression in 
Leydig cells, which could cause an increase in testosterone synthesis. Smaller concentrations 
of TiO2, carbon black, or diesel exhaust particles had no impact on Leydig cells (Komatsu et 
al. 2008), whereas Bradich-Stolle et al. (2005) showed that silver (Ag, 15 nm), molybdenum 
(MoO3, 30 nm), and aluminum (Al, 30 nm) nanoparticles at a concentration of 5 µg/ml 
increased leakage of lactate dehydrogenase from germ-line stem cells (Braydich-Stolle et al. 
2005). Taken together, these data suggest that studies using different kinds of nanoparticles, 
different cells types, and so forth yield varying results, making it difficult to draw definitive 
conclusions. However, a clear trend is emerging: in most of the published papers, toxic effects 
were observed only for high concentrations of particles (above 5 µg/ml). Thus, considering 
that our results showed that less than 1 out of 105 particle reached the testis after an 
intramuscular injection, this route can be considered as safe as long as the quantity of 
nanoparticles injected into mice does not exceed 50 mg. This value appears too high to be 
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clinically relevant or even realistic. Therefore, we may extrapolate that the probability of 
toxicity on the reproductive system is very low. 
 
CONCLUSIONS 
Negatively charged 70-nm silica nanoparticles were injected intramuscular to study the 
biodistribution and effects of colloidal solution on testes. Different physico-chemical 
detection techniques confirmed the absence of nanoparticles in this region of interest. 
Moreover, no histological toxicity signs were observed. This study is reassuring regarding 
reproductive toxicity concerns associated with the possible use of nanoparticles in 
intramuscular injections, especially as vaccine adjuvants. Further in-depth analyses with 
different exposure routes and various nanoparticle chemistries (e.g., varying size, surface, 
composition) should be performed to confirm the reproductive safety of nanoparticles. 
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FIGURES 
 
 
Figure 1: Physico-chemical characteristics of the nanoparticles injected into mice. A) Size 
distribution obtained by dynamic light scattering. B) Zeta potential (isoelectric pH). C) 
Transmission electron microscopy. Note the reproducibility of the 5-nm gold core. D) FITC 
fluorescence of the nanoparticles detected by epi-fluorescence microscopy. 
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Figure 2: Assessment of nanoparticles detection, morphological stability and ability to reach 
blood circulation after injection. (A) Quantification of gold in urine by means of ICP-AES. 
Results are expressed in parts per million (ppm). (B) Representative images of blood samples 
observed by TEM after filtration. White arrow shows a nanoparticle at D21.  
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Figure 3: ICP quantification of gold in the testes. Results are expressed in parts per million 
(ppm). Values are extremely low in each case and the data are not significantly different from 
the negative control (one-way ANOVA with Bonferroni comparison test, ***p < 0.001, 
Graphpad Prism 6). 
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Figure 4: Representative images of histological slides of testis. The left part of the figure 
shows images of H1 (A) and D36 (B) with normal morphological figures (equivalent to the 
control condition): (1) seminiferous tubule in cross-section (large tubular structure), (2) 
different types of germinal cells, (3) sperm (black, tiny, ovoid bodies), (4) tubular spaces with 
blood vessels and Leydig cells. The right part of the figure illustrates the different histological 
alterations observed. (C) Giant germinal cells with a large vacuolized cytoplasm, (D) 
desquameous germinal cells in the tubular lumen, (E) both, (F) empty tubule with only Sertoli 
cells. 
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Figure 5: Representative images of testis samples observed by TEM (H1, D4, D21, D36, and 
D45). (A) Germinal spermatogonia cell contiguous to the basement membrane of the 
seminiferous tubules (lower white arrow) and Sertoli cell forming the blood–testis barrier 
(upper white arrow). (B) Spermatocyte (white arrow). (C) Mature spermatozoids (black 
arrow). (D) Flagellum cross sections. (E, F) Intertubular spaces with Leydig cells, immune 
cells and vessels. No nanoparticles were detected in the H1, D4, D21, D36. and D45 samples. 
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Figure 6: HR imaging studies coupled with EDX analysis in the TOPCON electron 
microscope for different specimens of interest. The upper part of the figure displays the EDX 
spectra and the lower part shows the corresponding images of the analyzed regions. A) 
Control specimen corresponding to a drop of silica-gold nanoparticle suspension deposited on 
a sample slice. B) Image and spectrum from a D45 sample (representative of all the samples). 
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Figure 7: Confocal microscopy observations at the different times of sacrifice (A to H 
respectively: H1, D4, D21, D36, D45 and the control). The testes were imaged by reflection 
(gray level). The green fluorescence observed is not specific of the nanoparticles but instead 
corresponds to red blood cells (white arrow). 
 
